ProShare Advisors’s Natus Medical Inc NTUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-8,437
Closed -$200K 2339
2021
Q4
$200K Buy
+8,437
New +$208K ﹤0.01% 2035
2021
Q3
Sell
-9,672
Closed -$251K 2362
2021
Q2
$251K Sell
9,672
-320
-3% -$8.71K ﹤0.01% 2004
2021
Q1
$256K Buy
+9,992
New +$256K ﹤0.01% 1891
2018
Q1
Sell
-5,479
Closed -$209K 1777
2017
Q4
$209K Buy
+5,479
New +$219K ﹤0.01% 1618
2017
Q1
Sell
-5,957
Closed -$207K 1679
2016
Q4
$207K Buy
+5,957
New +$234K ﹤0.01% 1585
2016
Q1
Sell
-5,618
Closed -$270K 1666
2015
Q4
$270K Buy
+5,618
New +$260K ﹤0.01% 1351
2015
Q3
Sell
-4,757
Closed -$202K 1579
2015
Q2
$202K Sell
4,757
-2,308
-33% -$92K ﹤0.01% 1508
2015
Q1
$279K Sell
7,065
-672
-9% -$24.8K ﹤0.01% 1508
2014
Q4
$279K Sell
7,737
-5,860
-43% -$197K ﹤0.01% 1564
2014
Q3
$401K Sell
13,597
-3,224
-19% -$89K 0.01% 1540
2014
Q2
$423K Sell
16,821
-14,532
-46% -$359K 0.01% 1686
2014
Q1
$809K Buy
+31,353
New +$790K 0.01% 1471
2013
Q4
Sell
-19,835
Closed -$281K 1993
2013
Q3
$281K Sell
19,835
-462
-2% -$6.18K 0.01% 1942
2013
Q2
$277K Buy
+20,297
New +$277K 0.01% 1787

Other funds holding NTUS

ProShare Advisors's NTUS Position: Q1 2022 in Review

ProShare Advisors sold out of Natus Medical Inc (NTUS) in Q1 2022, closing a stake of 8,437 shares — an estimated $200K sold.

ProShare Advisors first reported a position in NTUS in Q2 2013 and held it in 14 quarters. The position peaked at $809K in Q1 2014. 172 funds tracked by Wall St. Rank hold NTUS as of Q1 2022.

  • ProShare Advisors reported no remaining Natus Medical Inc position as of Q1 2022 after selling out during the quarter.
  • ProShare Advisors sold 8,437 Natus Medical Inc shares in Q1 2022, an estimated $200K.
  • ProShare Advisors first reported a position in Natus Medical Inc in Q2 2013 and held it in 14 quarters.
  • ProShare Advisors's Natus Medical Inc position peaked at $809K in Q1 2014.
  • 172 funds tracked by Wall St. Rank held Natus Medical Inc as of Q1 2022.

Based on ProShare Advisors's 13F filing for Q1 2022, filed 10 May 2022.